Here we report a study describing p53 mutations, MYC, BCL-2 and BCL-6, translocations and immunohistochemical expression in a cohort of 155 newly diagnosed DLBCL cases. This evidence concerns the gene TP53 and diffuse large B-cell lymphoma.